Matthew L. Ulrickson
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Genetics
- Genetics
- Co-authors
- Olalekan O. OluwoleNatasha KekreSattva S. NeelapuYi LinChaitra S. UjjaniJulio C. ChávezAlex F. HerreraPeter A. Riedell
- Topics
- CAR-T cell therapy research (21 papers)Lymphoma Diagnosis and Treatment (12 papers)Chronic Lymphocytic Leukemia Research (5 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Matthew L. Ulrickson
27 papers receiving 396 citations
Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 313
- Pathology and Forensic Medicine 156
- Molecular Biology 77
- Genetics 70
- Genetics 66
Countries citing papers authored by Matthew L. Ulrickson
This map shows the geographic impact of Matthew L. Ulrickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Ulrickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Ulrickson more than expected).
Fields of papers citing papers by Matthew L. Ulrickson
This network shows the impact of papers produced by Matthew L. Ulrickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Ulrickson. The network helps show where Matthew L. Ulrickson may publish in the future.
Co-authorship network of co-authors of Matthew L. Ulrickson
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. Ulrickson. A scholar is included among the top collaborators of Matthew L. Ulrickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. Ulrickson. Matthew L. Ulrickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trialbreakdown → | 186 |
| 9 | 4 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 15 | |
| 15 | 12 | |
| 16 | 34 | |
| 17 | 4 | |
| 18 | 12 | |
| 19 | 29 | |
| 20 | 41 |
About Matthew L. Ulrickson
Matthew L. Ulrickson is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 35 papers that have together received 401 indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Lymphoma Diagnosis and Treatment (12 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Oncology (313 citations), Pathology and Forensic Medicine (156 citations) and Genetics (70 citations). Matthew L. Ulrickson has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Olalekan O. Oluwole, Natasha Kekre, Sattva S. Neelapu, Yi Lin, Chaitra S. Ujjani, Julio C. Chávez, Alex F. Herrera, Peter A. Riedell, Michael Dickinson and Sven de Vos. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.